These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6113835)

  • 21. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term clinical experience with clozapine].
    Gelly F; Chambon O; Marie-Cardine M
    Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Late dyskinesias in treatment with neuroleptics].
    Grecu G; Szücs K; Aşgian B; Grecu Căreanu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):249-59. PubMed ID: 6134327
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
    J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N; Keipes M; Graas M; Metz H
    Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
    Simon EW; Blubaugh KM; Pippidis M
    Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tolerance of bromperidol in long term application].
    Scelovic B
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():38-40. PubMed ID: 35477
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trial of Triperidol drop preparation in psychotic patients with severe autistic, abulic and refusing attitude resisting life-guidance or occupational therapy].
    Shimizu H; Sugimoto N
    Iryo; 1970 Jul; 24(7):547-55. PubMed ID: 5458294
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drugs as markers in identification. Detection of melperon (Buronil) in an adipoceratous corpse].
    Pollak S; Vycudilik W
    Arch Kriminol; 1986; 178(1-2):25-34. PubMed ID: 2876693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Re-examination of long-term drug therapy in mental diseases with special reference to its non-reversible side effects].
    Kazamatsuri H
    Seishin Shinkeigaku Zasshi; 1974 Oct; 76(10):663-7. PubMed ID: 4157044
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of single oral doses of various neuroleptic drugs on salivary secretion rate, pH, and buffer capacity in healthy subjects.
    Molander L; Birkhed D
    Psychopharmacology (Berl); 1981; 75(2):114-8. PubMed ID: 6119724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
    Haugen T
    Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
    [No Abstract]   [Full Text] [Related]  

  • 37. Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
    Röhricht F; Gadhia S; Alam R; Willis M
    ScientificWorldJournal; 2012; 2012():512047. PubMed ID: 22566771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient psychiatric medications and glaucoma.
    Reid WH; Blouin P
    Psychosomatics; 1976; 17(2):83-5. PubMed ID: 7801
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological data of the atypical neuroleptic compound melperone (Buronil).
    Christensson EG
    Acta Psychiatr Scand Suppl; 1989; 352():7-15. PubMed ID: 2573242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sedative effects and prolactin response to single oral doses of melperone.
    Molander L; Borgström L
    Psychopharmacology (Berl); 1983; 79(2-3):142-7. PubMed ID: 6133301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.